Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › WV › PT PLEASANT › PLEASANT VALLEY HOSPITAL, INC.

PLEASANT VALLEY HOSPITAL, INC.

NPI: 1598975120 · PT PLEASANT, WV 25550 · Medicare Defined Swing Bed Hospital Unit · NPI assigned 05/23/2007

$6.61M
Total Medicaid Paid
326,767
Total Claims
261,836
Beneficiaries
215
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialGROVES, TASHA (CREDENTIALING)
NPI Enumeration Date05/23/2007

Related Entities

Other providers sharing the same authorized official: GROVES, TASHA

ProviderCityStateTotal Paid
PLEASANT VALLEY HOSPITAL, INC. POINT PLEASANT WV $6.64M
POINT PLEASANT PHYSICIAN BILLING SERVICES PT PLEASANT WV $2.18M
PLEASANT VALLEY HOSPITAL INC MASON WV $1.01M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 68,782 $2.13M
2019 39,719 $616K
2020 60,061 $1.36M
2021 51,211 $890K
2022 35,149 $539K
2023 43,295 $632K
2024 28,550 $438K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 12,444 11,485 $942K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 3,075 2,680 $641K
99284 Emergency department visit for the evaluation and management, high severity 3,036 2,706 $279K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 28,457 22,290 $244K
80053 Comprehensive metabolic panel 18,170 15,538 $235K
99282 Emergency department visit for the evaluation and management, low to moderate severity 4,985 4,618 $225K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 7,029 1,923 $192K
36415 Collection of venous blood by venipuncture 34,278 24,303 $191K
80061 Lipid panel 8,417 7,908 $113K
80048 Basic metabolic panel (calcium, ionized) 11,419 8,533 $108K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 3,995 3,591 $107K
84443 Thyroid stimulating hormone (TSH) 7,415 6,836 $104K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2,803 1,503 $103K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 4,490 3,865 $99K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 1,709 465 $94K
96361 Intravenous infusion, hydration; each additional hour 2,495 1,833 $93K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 913 859 $86K
70450 Computed tomography, head or brain; without contrast material 1,720 1,530 $84K
74177 Computed tomography, abdomen and pelvis; with contrast material 643 583 $73K
74176 Computed tomography, abdomen and pelvis; without contrast material 862 775 $71K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 3,470 3,189 $69K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 5,214 4,356 $65K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 2,869 886 $64K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 3,536 2,813 $64K
71046 Radiologic examination, chest; 2 views 3,158 2,872 $63K
84484 3,612 2,584 $62K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 2,771 2,525 $59K
83036 Hemoglobin; glycosylated (A1C) 6,082 5,668 $57K
83735 5,541 4,401 $57K
82550 2,087 1,722 $54K
71045 Radiologic examination, chest; single view 4,364 3,775 $52K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 2,501 755 $52K
82553 1,596 1,304 $51K
99281 Emergency department visit for the evaluation and management, self-limited or minor 2,178 2,049 $50K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2,604 2,249 $49K
81001 5,693 5,032 $48K
96375 Therapeutic injection; each additional sequential IV push 2,685 2,056 $48K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 5,684 4,634 $48K
83874 1,574 1,283 $47K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 243 216 $46K
80076 2,687 2,447 $41K
83690 2,766 2,453 $40K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 438 373 $38K
84439 3,257 3,046 $37K
97530 Therapeutic activities, direct patient contact, each 15 minutes 1,330 446 $37K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 1,033 976 $37K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 672 604 $36K
82150 1,516 1,351 $34K
80348 3,027 2,586 $31K
85610 3,367 2,411 $30K
81003 2,685 2,442 $30K
87086 Culture, bacterial; quantitative colony count, urine 2,932 2,616 $29K
80074 511 475 $28K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 94 85 $27K
81025 994 910 $27K
77067 Screening mammography, bilateral, including computer-aided detection 398 378 $24K
83605 2,178 1,819 $23K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 110 98 $23K
83880 1,066 905 $23K
85730 1,483 1,323 $22K
82607 1,731 1,618 $22K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 645 630 $21K
93017 114 100 $19K
94761 410 344 $19K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 985 934 $18K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 481 443 $18K
87186 1,729 1,563 $17K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 678 560 $17K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 459 426 $17K
J2785 Injection, regadenoson, 0.1 mg 79 70 $15K
85027 1,252 1,020 $15K
97162 435 400 $15K
G0378 Hospital observation service, per hour 352 282 $15K
87807 1,083 1,018 $14K
73630 399 363 $14K
85007 1,216 994 $14K
76705 Ultrasound, abdominal, real time with image documentation; limited 222 211 $14K
83992 876 838 $14K
80346 907 866 $13K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 176 158 $13K
84145 1,165 1,001 $12K
82248 390 340 $12K
87486 161 144 $11K
87581 161 144 $11K
80305 575 504 $11K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 326 289 $10K
74022 411 377 $10K
73610 244 218 $10K
87040 826 673 $10K
80361 896 854 $10K
87088 649 592 $9K
J0131 Injection, acetaminophen, not otherwise specified,10 mg 55 42 $9K
96376 406 232 $9K
87522 Neg quan hep c or qual rna 209 138 $8K
P9603 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled 8,407 4,982 $8K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 14 13 $8K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 579 444 $8K
83540 1,275 1,188 $8K
73562 249 230 $8K
80326 894 853 $8K
84481 633 594 $8K
72110 214 203 $8K
86886 364 351 $7K
80360 899 855 $7K
82947 945 890 $7K
87205 317 275 $6K
82948 186 86 $6K
80373 894 853 $6K
87070 293 257 $6K
80354 877 839 $6K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 293 177 $6K
82565 693 618 $6K
73130 99 93 $6K
83550 864 807 $6K
86780 423 367 $5K
87517 148 97 $5K
94664 216 154 $5K
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 338 296 $5K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 84 77 $5K
88305 Level IV - Surgical pathology, gross and microscopic examination 93 88 $5K
A9270 Non-covered item or service 2,640 1,348 $5K
87081 555 524 $5K
73030 149 138 $5K
86592 126 106 $4K
86480 77 56 $4K
85651 530 448 $4K
76536 65 64 $4K
84550 98 90 $4K
82043 379 352 $4K
80355 907 866 $4K
80358 895 853 $4K
80371 894 853 $4K
80367 894 853 $4K
80372 894 853 $4K
80370 894 853 $4K
80365 894 853 $4K
80368 894 853 $4K
80364 877 839 $4K
80359 877 839 $4K
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 273 242 $4K
82746 331 314 $4K
97161 116 105 $4K
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge 2,116 1,424 $4K
82728 445 404 $4K
87077 131 115 $4K
84460 398 379 $3K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 29 25 $3K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 105 92 $3K
84132 424 400 $3K
86803 82 77 $3K
88142 53 48 $3K
73110 31 24 $3K
86140 533 435 $3K
80353 520 493 $2K
80366 513 488 $2K
80321 141 120 $2K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 122 115 $2K
86704 192 120 $2K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis 18 12 $2K
86705 17 17 $1K
77063 Screening digital breast tomosynthesis, bilateral 109 104 $1K
86706 156 101 $1K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 55 25 $1K
80349 121 100 $1K
83525 98 96 $1K
87340 137 87 $1K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 15 13 $1K
84295 280 265 $1K
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml 56 51 $1K
84520 176 164 $1K
97165 26 26 $1K
85379 100 95 $907.49
97116 53 25 $889.34
94760 77 56 $860.06
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 24 22 $842.75
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 54 40 $759.62
86708 62 44 $673.81
82172 42 24 $632.99
76830 Ultrasound, transvaginal 13 13 $627.00
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 990 897 $590.68
80164 13 13 $562.76
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 27 24 $499.06
80050 General health panel 14 14 $459.22
83883 42 24 $447.85
83010 42 24 $414.24
85018 18 17 $396.87
85014 18 17 $396.87
87350 20 13 $332.16
93880 13 12 $301.94
J3490 Unclassified drugs 931 391 $274.39
G8985 Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 20 14 $273.79
G8984 Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals 20 14 $273.79
82977 42 24 $237.08
72100 20 12 $227.59
84153 14 14 $224.92
97597 22 12 $213.30
86901 26 24 $210.18
86900 26 24 $210.18
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 15 13 $177.36
86141 13 12 $137.53
71101 13 13 $127.38
90686 58 55 $121.44
J1885 Injection, ketorolac tromethamine, per 15 mg 457 335 $117.22
86850 13 12 $112.82
83615 18 13 $59.29
84450 13 13 $53.97
J2405 Injection, ondansetron hydrochloride, per 1 mg 704 488 $47.61
J0696 Injection, ceftriaxone sodium, per 250 mg 257 143 $39.10
J2704 Injection, propofol, 10 mg 84 63 $28.69
G0008 Administration of influenza virus vaccine 77 75 $21.11
84100 14 12 $15.89
J1100 Injection, dexamethasone sodium phosphate, 1 mg 193 114 $10.51
J1170 Injection, hydromorphone, up to 4 mg 54 24 $6.51
J8499 Prescription drug, oral, non chemotherapeutic, nos 1,313 403 $2.77
J2250 Injection, midazolam hydrochloride, per 1 mg 15 13 $0.76